Sculati Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.5M Buy
17,321
+342
+2% +$32.8K 0.55% 53
2025
Q4
$1.63M Sell
16,979
-1,275
-7% -$124K 0.57% 51
2025
Q3
$1.74M Buy
18,254
+190
+1% +$17.5K 0.61% 48
2025
Q2
$1.57M Buy
18,064
+776
+4% +$65.8K 0.59% 53
2025
Q1
$1.55M Buy
17,288
+2,587
+18% +$231K 0.63% 46
2024
Q4
$1.17M Buy
14,701
+175
+1% +$15.1K 0.46% 53
2024
Q3
$1.31M Buy
14,526
+2,572
+22% +$216K 0.52% 50
2024
Q2
$941K Buy
11,954
+3,527
+42% +$289K 0.4% 60
2024
Q1
$734K Buy
+8,427
New +$719K 0.32% 68

Other funds holding MDT

Sculati Wealth Management's MDT Position: Q1 2026 in Review

Sculati Wealth Management increased its Medtronic (MDT) stake by 2% in Q1 2026, buying an estimated $32.8K and bringing the position to 17,321 shares worth $1.5M. The position accounts for 0.55% of the portfolio, ranked #53.

Sculati Wealth Management first reported a position in MDT in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.74M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Sculati Wealth Management held 17,321 shares of Medtronic worth $1.5M as of Q1 2026.
  • Sculati Wealth Management bought 342 Medtronic shares in Q1 2026, an estimated $32.8K.
  • Medtronic made up 0.55% of Sculati Wealth Management's portfolio in Q1 2026, its #53 holding.
  • Sculati Wealth Management first reported a position in Medtronic in Q1 2024 and has held it in 9 quarters since.
  • Sculati Wealth Management's Medtronic position peaked at $1.74M in Q3 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Sculati Wealth Management's 13F filing for Q1 2026, filed 9 Apr 2026.